How this company measures up on the fundamentals that matter
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Trading at $275 against a fair value of $382, a 28% discount. Fails ethical screen (Interest-bearing securities). Ranks better than 55% of screened stocks.
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Trading characteristics and market positioning
Balance sheet strength and cash generation — the foundation of long-term value
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-01 | VENTURA JOSEPH CHRISTOPHER | Officer | 10,318 | — | |
| 2026-05-01 | O'HARA MICHELLE A. | Officer | 10,485 | — | |
| 2026-05-01 | SHETTY SANJAY K | Officer | 9,945 | — | |
| 2026-05-01 | RECHTIN JAMES A. | Chief Executive Officer | 35,633 | — | |
| 2026-05-01 | DINTENFASS DAVID | Officer | 11,273 | — | |
| 2026-05-01 | MEHTA JAPAN | Chief Technology Officer | 9,448 | — | |
| 2026-05-01 | MELLET CELESTE | Chief Financial Officer | 15,387 | — | |
| 2026-05-01 | MARTIN AARON | Officer | 8,206 | — | |
| 2026-05-01 | FIELD ROBERT STUART | Director | 852 | — | |
| 2026-04-01 | SHETTY SANJAY K | Officer | 887 | — |
Congressional trading disclosures involving this instrument
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 1K–15K |
Data sourced from public filings and market feeds. Not financial advice. Updated: 2025-12-31